gabriele carmine deluca
University of Oxford
Oxford, United Kingdom
Review Editor
Multiple Sclerosis and Neuroimmunology
University of Oxford
Oxford, United Kingdom
Review Editor
Multiple Sclerosis and Neuroimmunology
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Utah
Salt Lake City, United States
Review Editor
Multiple Sclerosis and Neuroimmunology
Innsbruck Medical University
Innsbruck, Austria
Review Editor
Multiple Sclerosis and Neuroimmunology
Mexican Social Security Institute (IMSS)
Mexico City, Mexico
Review Editor
Multiple Sclerosis and Neuroimmunology
University of Calgary
Calgary, Canada
Review Editor
Multiple Sclerosis and Neuroimmunology
Süleyman Demirel University
Isparta, Türkiye
Review Editor
Multiple Sclerosis and Neuroimmunology
University of Perugia
Perugia, Italy
Review Editor
Multiple Sclerosis and Neuroimmunology
Innsbruck Medical University
Innsbruck, Austria
Review Editor
Multiple Sclerosis and Neuroimmunology
White River Junction VA Medical Center, United States Department of Veterans Affairs
White River Junction, United States
Review Editor
Multiple Sclerosis and Neuroimmunology
Hospital de Base do Distrito Federal
Brasilia, Brazil
Review Editor
Multiple Sclerosis and Neuroimmunology
Klinik für Neurologie, Universitätsklinikum Düsseldorf
Dusseldorf, Germany
Review Editor
Multiple Sclerosis and Neuroimmunology
Hospital Virgen del Puerto
Plasencia, Spain
Review Editor
Multiple Sclerosis and Neuroimmunology
Siniša Stanković Institute for Biological Research, University of Belgrade
Belgrade, Serbia
Review Editor
Multiple Sclerosis and Neuroimmunology
INSERM U1237 Physiopathologie et imagerie des troubles Neurologiques (PhIND)
Caen, France
Review Editor
Multiple Sclerosis and Neuroimmunology
Dumfries and Galloway Royal Infirmary
Dumfries, United Kingdom
Review Editor
Multiple Sclerosis and Neuroimmunology
Dumfries and Galloway Royal Infirmary
Dumfries, United Kingdom
Review Editor
Multiple Sclerosis and Neuroimmunology